Skip to content
Disclosery

Data Collective IV GP, LLC

Follow

13F filer, CIK 1664974, PALO ALTO, CA

Data Collective IV GP, LLC reported $78,552,270 across 4 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-097077

Period
2026-06-30
Reported value
$78.6M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001104659-26-097077, largest first. % of portfolio is the value over $78,552,270, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVLVEVOLV TECHNOLOGIES HLDNGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,681,281 shares; 2024Q4: 9,681,281 shares; 2025Q1: 9,681,281 shares; 2025Q2: 9,681,281 shares; 2025Q3: 5,000,000 shares; 2025Q4: 4,590,000 shares; 2026Q1: 4,590,000 shares; 2026Q2: 4,590,000 shares 4,590,000$26.6M33.89%0Timeline
HQHORIZON QUANTUM HOLDINGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 915,198 shares; 2026Q2: 915,198 shares 915,198$25.4M32.34%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,941,120 shares; 2024Q4: 5,941,120 shares; 2025Q1: 5,941,120 shares; 2025Q2: 5,941,120 shares; 2025Q3: 5,941,120 shares; 2025Q4: 5,941,120 shares; 2026Q1: 5,941,120 shares; 2026Q2: 5,941,120 shares 5,941,120$21.8M27.76%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,350 shares; 2026Q2: 100,350 shares 100,350$4.72M6.01%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-097077 base2026-08-14acceptance time not in the bulk data set